Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 162

Results For "EU"

6769 News Found

Novartis locks in $23 billion US expansion with seventh new facility
News | May 05, 2026

Novartis locks in $23 billion US expansion with seventh new facility

The latest addition, a new API facility in Morrisville, North Carolina, will produce key components for solid dosage tablets, capsules, and RNA therapeutics


OBESITAS 2026 concludes with focus on India’s rising obesity burden
Healthcare | May 05, 2026

OBESITAS 2026 concludes with focus on India’s rising obesity burden

The conference brought together over 500 doctors and 150 nutritionists to discuss emerging obesity-related challenges


Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh
Policy | May 05, 2026

Govt, academia and industry collaboration crucial for scientific progress: Dr Jitendra Singh

The Minister emphasised that scientific institutions must actively communicate their achievements and engage with stakeholders


Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025
Biopharma | May 05, 2026

Swiss Biotech Association reports CHF 7.5 billion revenue for Switzerland’s biotech Industry in 2025

The private funding rose 38% amid growing international collaborations and CDMO demand


OneSource powers second generic semaglutide nod in Canada
Drug Approval | May 05, 2026

OneSource powers second generic semaglutide nod in Canada

Approval marks the second generic semaglutide clearance in Canada and strengthens OneSource’s position in complex injectable CDMO programs


Lupin receives USFDA approval for generic Ravicti oral liquid
Drug Approval | May 05, 2026

Lupin receives USFDA approval for generic Ravicti oral liquid

Approval expands Lupin’s specialty portfolio in the US market for treatment of urea cycle disorders


India and Japan deepen healthcare collaboration at 3rd joint committee meeting
Policy | May 05, 2026

India and Japan deepen healthcare collaboration at 3rd joint committee meeting

Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development


Zydus Lifesciences subsidiary faces Rs 9 million GST demand notice
Biopharma | May 05, 2026

Zydus Lifesciences subsidiary faces Rs 9 million GST demand notice

Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims


NIFTY Pharma remains resilient amid mixed market sentiment
News | May 05, 2026

NIFTY Pharma remains resilient amid mixed market sentiment

Pharma and healthcare stocks stay in focus as investors track earnings, USFDA approvals, hospital growth, and global market pressures


Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations
Digitisation | May 05, 2026

Indegene named leader in ISG provider lens 2026 for life sciences digital commercial operations

The ISG assessment highlights Indegene’s deep domain expertise, proprietary technology stack, and expanding use of AI and GenAI to drive more integrated, data-led commercial execution across the life sciences value chain